ORBi: Jerusalem Guy - Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

Reference : Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vino...


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Oncology
	To cite this reference:	http://hdl.handle.net/2268/76020

Title :	Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
Language :	English
Author, co-author :	Jerusalem, Guy [Université de Liège - ULg > > Oncologie médicale >]
	Fasolo, Angelica [> >]
	Dieras, Véronique [> >]
	Cardoso, Fatima [> >]
	Bergh, Jonas [> >]
	Vittori, Luc [> >]
	Zhang, Yufen [> >]
	Massacesi, Cristian [> >]
	Sahmoud, Tarek [> >]
	Gianni, Luca [> >]
Publication date :	Jan-2011
Journal title :	Breast Cancer Research and Treatment
Publisher :	Kluwer Academic Publishers
Volume :	125
Issue/season :	2
Pages :	447-455
Audience :	International
ISSN :	0167-6806
City :	Dordrecht
Country :	The Netherlands
Keywords :	[en] mTOR ; everolimus ; trastuzumab ; vinorelbine ; phase I ; HER2-overexpressing metastatic breast cancer ; oncology
Target :	Researchers ; Professionals
Permalink :	http://hdl.handle.net/2268/76020

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Phase I trial of oral mTOR inhibitor.pdf		Publisher postprint	733.8 kB	Request copy

All documents in ORBi are protected by a user license.